Cargando…
Benefits from standalone durvalumab treatment in an elderly patient with advanced prostatic sarcoma: a case report
There is a lacking of effective therapeutic strategies in the treatment of advanced prostatic sarcoma with high-frequency microsatellite instability (MSI-H) or mismatch repair deficient (dMMR). In this study, we present the first described a case of advanced MSI-H and dMMR prostatic sarcoma in elder...
Autores principales: | Wang, Lili, Wang, Lei, Hou, Dingkun, Dong, Shiqiang, Wang, Aixiang, Wang, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661254/ https://www.ncbi.nlm.nih.gov/pubmed/34984194 http://dx.doi.org/10.21037/tau-21-125 |
Ejemplares similares
-
A comprehensive characterization of the transcriptome in enzalutamide resistance prostate cancer
por: Wang, Lili, et al.
Publicado: (2021) -
Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021) -
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022) -
MS Amanda 2.0: Advancements in the standalone implementation
por: Dorfer, Viktoria, et al.
Publicado: (2021) -
An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review
por: Dong, Shiqiang, et al.
Publicado: (2020)